5-Amino-1MQ (related non-peptide)
An experimental NNMT inhibitor, not a peptide.
Investigational / no FDA-approved-treatment claim
An experimental NNMT inhibitor, not a peptide.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Purported uses, not established benefits
Proponents claim 5-Amino-1MQ may affect energy metabolism and body fat by inhibiting NNMT.
The 2024 paper studies obesity-related dysfunction in mouse models. It does not establish effective or safe human weight management.
Evidence and source limits
The source linked here describes research or investigational use. It does not establish an FDA-approved indication for this compound or for a research-chemical product. A claimed use is not an established benefit.
Product identity, purity, route, safety and suitability remain separate questions. Research-purpose-only labeling does not authorize human use. This note provides no dosing, preparation or purchase guidance.
Original source: 5-Amino-1MQ (related non-peptide) ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.